The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 24, 2022

Filed:

Oct. 03, 2019
Applicant:

Ossianix, Inc., Philadelphia, PA (US);

Inventors:

Julien Häsler, Hoogstraten, BE;

Julia Lynn Rutkowski, Bryn Mawr, PA (US);

Assignee:

Ossianix, Inc., Philadelphia, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C40B 40/10 (2006.01); C12N 15/10 (2006.01); C07K 16/28 (2006.01); C07K 16/00 (2006.01); C07K 16/22 (2006.01); C40B 40/08 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1055 (2013.01); C07K 16/00 (2013.01); C07K 16/005 (2013.01); C07K 16/22 (2013.01); C07K 16/2875 (2013.01); C07K 16/2881 (2013.01); C12N 15/1037 (2013.01); C07K 2317/20 (2013.01); C07K 2317/565 (2013.01); C07K 2317/567 (2013.01); C07K 2317/569 (2013.01); C07K 2317/72 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2319/30 (2013.01); C40B 40/08 (2013.01); C40B 40/10 (2013.01);
Abstract

The present invention relates to VNAR single chain antibodies and more particularly, to semi-synthetic VNAR libraries derived from nurse shark which may be used to identify individual clones, nucleic acid molecules and polypeptides which encode binding moieties that specifically bind to a cellular target of interest, thereby altering (e.g., antagonizing) target activity in a cell or mimicking the activity of a native molecule. The present invention thus also relates to compounds and compositions comprising a target specific VNAR binding moiety, methods for preparing them, and diagnostic and therapeutic methods of use relating to regulation, e.g., agonism or antagonism of the selected cellular target or target pathway e.g., to treat and/or prevent a pathological condition, disorder or disease in which it is beneficial to alter, e.g., agonize or augment, antagonize, reduce or eliminate the specific cellular target activity.


Find Patent Forward Citations

Loading…